Peter Binas - Profile and Investment Details

Investor Profile

Peter Binas is a Venture Capital, Private Equity Firm based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Millstone Medical, Mimetogen Pharmaceuticals, Cullinan Oncology, CustomMade, eXIthera Pharmaceuticals, Best Doctors, Top10 Media, Maxwell Health, RailComm, Breezeway, SeLux Diagnostics, MediaSilo, Zixi, Fashion Project, SRS Medical Systems, Spotted, Cartesian Therapeutics, Remedy Plan Therapeutics, Seventh Generation, East Point Capital, 4G Clinical, SHIFTCensinet, Topokine Therapeutics, Commonwealth Fusion, F&B Asia, IndoStar Capital, Cyft, Zippity, Nanoscale Powders, Emerald Cloud Lab, StyleFeeder, Wren Therapeutics, . Over time, Peter Binas has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Peter Binas is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Cybersecurity, Home Services, Energy, CRM, Automotive, Electrical Distribution, Information Technology (IT), Software, Biotechnology, Consumer Internet, Logistics, Health Diagnostics, Renewable Energy, Medical, SaaS, Real Estate, Therapeutics, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Peter Binas, as their portfolio suggests a familiarity and interest in this area.

Understanding Peter Binas’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.